Anderman Jonathan bought CMPX
January 2, 2026 · Form 4 insider transaction
Anderman Jonathan bought 720,000 shares of Compass Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
720,000
Price
$0.00
Total value
N/A
InsiderAnderman Jonathan
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after720,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest over 48 substantially equal monthly installments starting February 2, 2026.